Emergent said it is separately working on increasing the availability of its ove...
As a major report highlights the challenges of a struggling NHS, the call for pr...
The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaem...
Purespring Therapeutics has raised $105m in a Series B funding round which will ...
Discover the leading Clinical Dose Companies in Contract Manufacturing. Download...
The company employs machine learning to uncover disease mechanisms at the mRNA l...
The deal allows MSD to license one or more therapies against inflammatory diseas...
mRNA-based vaccines, which instruct cells to produce proteins that can prevent o...
NP001 is designed to tackle the neurodegenerative disease through an immunologic...
The safety review was requested by the French medicines agency, citing new safet...
The company intends to start a registrational Phase II trial of pelareorep and c...
US hedge fund Starboard now holds 0.6% of Pfizer’s value as the drugmaker strugg...
ProductLife Group (PLG) has announced the acquisition of IntiQuan, a Swiss firm ...
Health Canada has expanded the approved use of Telix Pharmaceuticals' Illuccix f...
OnKure has announced the successful completion of its merger with Reneo Pharmace...
The CD7 CAR)-T cell therapy has demonstrated potential in treating patients with...
